Your browser doesn't support javascript.
loading
CYP3A4*22 and bleeding risk in ticagrelor users.
Asiimwe, Innocent G; Pirmohamed, Munir.
Affiliation
  • Asiimwe IG; The Wolfson Centre for Personalized Medicine, MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
  • Pirmohamed M; The Wolfson Centre for Personalized Medicine, MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Basic Clin Pharmacol Toxicol ; 134(3): 311-314, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38163812
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Coronary Syndrome / Percutaneous Coronary Intervention Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Basic Clin Pharmacol Toxicol Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2024 Document type: Article Affiliation country: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Coronary Syndrome / Percutaneous Coronary Intervention Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Basic Clin Pharmacol Toxicol Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2024 Document type: Article Affiliation country: Reino Unido